Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 17, 2024 16:11 ET | Source: Robbins LLP

VTYX Stockholders are Encouraged to Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Ventyx Biosciences, Inc. Class Action

Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug
March 26, 2024 00:27 ET | Source: Robbins LLP

VTYX Stockholders with Large Losses Should Contact Robbins LLP to Learn More about the Ventyx Biosciences, Inc. Class Action

Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug
March 14, 2024 00:01 ET | Source: Robbins LLP

VTYX STOCKHOLDER NEWS: Contact Robbins LLP for Information Regarding the Ventyx Biosciences, Inc. Class Action

Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug
March 04, 2024 17:33 ET | Source: Robbins LLP

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Ventyx Biosciences, Inc. (VTYX)

Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug